The miR-23b decreased the migration and proliferation abilities of HCC cells by downregulating c-Met and urokinase-type plasminogen activator, the latter of which is a critical functional downstream target of HGF/c-Met signalling (Salvi et al, 2009). This evidence concerns the gene MET and hepatocellular carcinoma.